Neville Marks

4.6k total citations
119 papers, 3.6k citations indexed

About

Neville Marks is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Neville Marks has authored 119 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 51 papers in Cellular and Molecular Neuroscience and 32 papers in Oncology. Recurrent topics in Neville Marks's work include Neuropeptides and Animal Physiology (40 papers), Peptidase Inhibition and Analysis (32 papers) and Protein Hydrolysis and Bioactive Peptides (22 papers). Neville Marks is often cited by papers focused on Neuropeptides and Animal Physiology (40 papers), Peptidase Inhibition and Analysis (32 papers) and Protein Hydrolysis and Bioactive Peptides (22 papers). Neville Marks collaborates with scholars based in United States, Bulgaria and United Kingdom. Neville Marks's co-authors include M. Benuck, Martin J. Berg, Ábel Lajtha, Yasuko F. Jacquet, Frederic Stern, Alice Grynbaum, Randall H. Kramer, Richard Rodnight, Mariko Saito and Joseph B. Hellige and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Neville Marks

119 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neville Marks United States 34 2.1k 1.4k 767 580 553 119 3.6k
Hachiro Nakagawa Japan 32 2.0k 0.9× 627 0.4× 1.2k 1.5× 367 0.6× 453 0.8× 132 4.3k
Michio Niinobe Japan 33 3.0k 1.4× 1.3k 0.9× 700 0.9× 324 0.6× 1.3k 2.4× 64 4.7k
M. Sensenbrenner France 40 3.6k 1.7× 2.6k 1.8× 583 0.8× 222 0.4× 825 1.5× 149 6.0k
Michael D. Uhler United States 35 3.2k 1.6× 1.0k 0.7× 570 0.7× 377 0.7× 548 1.0× 85 4.4k
Lucy Rhee United States 13 3.6k 1.8× 1.8k 1.2× 294 0.4× 283 0.5× 424 0.8× 13 4.8k
Hiroshi Kase Japan 38 3.1k 1.5× 1.8k 1.3× 465 0.6× 252 0.4× 301 0.5× 123 5.8k
F. Van Leuven Belgium 38 2.6k 1.3× 1.2k 0.8× 2.8k 3.7× 286 0.5× 696 1.3× 75 5.2k
James Douglass United States 26 2.1k 1.0× 1.7k 1.2× 608 0.8× 297 0.5× 323 0.6× 36 4.0k
Sebastián Pons Spain 40 3.9k 1.9× 1.2k 0.8× 983 1.3× 332 0.6× 360 0.7× 77 6.0k
Jobst Sievers Germany 39 1.7k 0.8× 2.2k 1.5× 400 0.5× 255 0.4× 315 0.6× 97 4.8k

Countries citing papers authored by Neville Marks

Since Specialization
Citations

This map shows the geographic impact of Neville Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neville Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neville Marks more than expected).

Fields of papers citing papers by Neville Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neville Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neville Marks. The network helps show where Neville Marks may publish in the future.

Co-authorship network of co-authors of Neville Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Neville Marks. A scholar is included among the top collaborators of Neville Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neville Marks. Neville Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nash, Kevin, María del Carmen Cárdenas‐Aguayo, Martin J. Berg, & Neville Marks. (2012). Transduction of E13 murine neural precursor cells by non-immunogenic recombinant adeno-associated viruses induces major changes in neuronal phenotype. Neuroscience. 210. 82–98. 2 indexed citations
2.
Marks, Neville & Martin J. Berg. (2009). BACE and γ-Secretase Characterization and Their Sorting as Therapeutic Targets to Reduce Amyloidogenesis. Neurochemical Research. 35(2). 181–210. 26 indexed citations
3.
Marks, Neville & Martin J. Berg. (2007). Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders. Neurochemistry International. 52(1-2). 184–215. 26 indexed citations
4.
Baslow, Morris H., Raymond F. Suckow, Kate Gaynor, et al.. (2003). Brain Damage Results in Down-Regulation of N-Acetylaspartate as a Neuronal Osmolyte. NeuroMolecular Medicine. 3(2). 95–104. 24 indexed citations
5.
Marks, Neville & Joseph B. Hellige. (2003). Interhemispheric Interaction in Bilateral Redundancy Gain: Effects of Stimulus Format.. Neuropsychology. 17(4). 578–593. 22 indexed citations
6.
Hellige, Joseph B. & Neville Marks. (2001). Are hemispheric strategy differences independent of the level of performance?. Neuropsychology. 15(3). 380–395. 12 indexed citations
8.
Marks, Neville & Joseph B. Hellige. (1999). Effects of bilateral stimulation and stimulus redundancy on interhemispheric interaction.. Neuropsychology. 13(4). 475–487. 31 indexed citations
9.
Saito, Mariko, Martin J. Berg, Alessandro Guidotti, & Neville Marks. (1999). Gangliosides Attenuate Ethanol-Induced Apoptosis in Rat Cerebellar Granule Neurons. Neurochemical Research. 24(9). 1107–1115. 33 indexed citations
11.
Sapirstein, Victor S., et al.. (1994). Amyloid precursor protein is enriched in axolemma and periaxolemmal‐myelin and associated clathrin‐coated vesicles. Journal of Neuroscience Research. 37(3). 348–358. 28 indexed citations
12.
Marks, Neville, Martin J. Berg, Jennifer Choi, et al.. (1994). Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles. Peptides. 15(1). 175–182. 22 indexed citations
14.
Marks, Neville, Martin J. Berg, Raymond Makofske, & Waleed Danho. (1990). Synthetic domains of cystatins linked to enkephalins are novel inhibitors of brain cathepsins L/B. Peptides. 11(4). 679–682. 6 indexed citations
15.
Marks, Neville, Martin J. Berg, & Waleed Danho. (1989). Enkephalin analogs as substrates for the assay of brain cysteine proteinase (Cathepsin L) and its endogenous inhibitors. Peptides. 10(2). 391–394. 3 indexed citations
16.
Marks, Neville, et al.. (1988). Diversity of rat brain cysteine proteinase inhibitors: Isolation of low-molecular-weight cystatins and a higher-molecular weight T-kininogen-like glycoprotein. Archives of Biochemistry and Biophysics. 267(2). 448–458. 9 indexed citations
18.
Marks, Neville, Abba J. Kastin, Frederic Stern, & David H. Coy. (1978). Metabolism of potent enkephalin analogs (FK 33–824, D-Ala2, pentafluorophenylalanine-4-enkephalinamide and a dimer of D-Ala2-enkephalin) and D-amino acid substituted derivatives of human β-endorphin. Brain Research Bulletin. 3(6). 687–690. 11 indexed citations
19.
Benuck, M., Alice Grynbaum, Thomas B. Cooper, & Neville Marks. (1978). Conversion of lipotropic peptides by purified cathepsin D of human pituitary: Release of γ-endorphin by cleavage of the Leu77-PHE78 bond. Neuroscience Letters. 10(1-2). 3–9. 14 indexed citations
20.
Marks, Neville, Alice Grynbaum, & Ábel Lajtha. (1976). The breakdown of myelin-bound proteins by intra- and extracellular proteases. Neurochemical Research. 1(1). 93–111. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026